Original Research

Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1–Diagnosed Adults

LaMori J, Seignez A, Radoszycki L

Patient Preference and Adherence 2022, 16:83-94

Published Date: 13 January 2022